HIF1A and breast carcinoma: Interestingly, our previous studies showed that Mint3 maintains HIF-1 activity during normoxia but does not affect in vitro cell proliferation of breast cancer MDA-MB-231 and fibrosarcoma HT1080 cells [14, 15, 17], which is in contrast to our findings in pancreatic cancer cells.